The divestiture of the Unomedical wound care and ophthalmics business was a requirement of the European Commission following the acquisition of ConvaTec by Nordic Capital and Avista Capital Partners and the subsequent integration of the Unomedical business with ConvaTec.
Under the terms of the agreement, Aspen has acquired the entire Unomedical wound care and ophthalmics business activities as a going concern, including all personnel and the continued use of the facilities in Redditch, UK. Financial terms of the agreement are not being disclosed.
PriceWaterhouseCoopers has served as corporate finance advisor for ConvaTec and The Wilkes Partnership served as legal counsel for the company.